Page last updated: 2024-09-04

sodium salicylate and pd 98059

sodium salicylate has been researched along with pd 98059 in 1 studies

Compound Research Comparison

Studies
(sodium salicylate)
Trials
(sodium salicylate)
Recent Studies (post-2010)
(sodium salicylate)
Studies
(pd 98059)
Trials
(pd 98059)
Recent Studies (post-2010) (pd 98059)
2,031501714,93931,001

Protein Interaction Comparison

ProteinTaxonomysodium salicylate (IC50)pd 98059 (IC50)
RAF proto-oncogene serine/threonine-protein kinaseHomo sapiens (human)2.8
Luciferin 4-monooxygenasePhotinus pyralis (common eastern firefly)6.3
Amine oxidase [flavin-containing] BRattus norvegicus (Norway rat)2.8
Prostaglandin G/H synthase 1Homo sapiens (human)1
Mitogen-activated protein kinase 1Homo sapiens (human)2.8
Dual specificity mitogen-activated protein kinase kinase 2 Rattus norvegicus (Norway rat)4.2
Dual specificity mitogen-activated protein kinase kinase 1 Rattus norvegicus (Norway rat)4.2
Dual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)2.4

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chae, HJ; Chae, SW; Kim, HR; Reed, JC1

Other Studies

1 other study(ies) available for sodium salicylate and pd 98059

ArticleYear
Salicylate regulates COX-2 expression through ERK and subsequent NF-kappaB activation in osteoblasts.
    Immunopharmacology and immunotoxicology, 2004, Volume: 26, Issue:1

    Topics: Animals; Antioxidants; Blotting, Western; Cell Line; Cyclooxygenase 2; Dinoprostone; Electrophoretic Mobility Shift Assay; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Gene Expression Regulation; I-kappa B Proteins; Interferon-gamma; Isoenzymes; MAP Kinase Kinase 1; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; NF-kappa B; Osteoblasts; Phosphorylation; Prostaglandin-Endoperoxide Synthases; Reactive Oxygen Species; Signal Transduction; Sodium Salicylate; Tumor Necrosis Factor-alpha

2004